Cocrystal Highlights CDI-988 Oral Antiviral for Norovirus Infection
September 12, 2025
Cocrystal Pharma, Inc. announces that President and co-CEO Sam Lee, PhD discussed the scientific foundation and clinical progress with the Company’s lead pan-viral protease inhibitor